Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Double Blind , Randomized, Multicenter Study of Second Line Treatment of Endostar(rh Recombined Endostatin)With Single Docetaxel In NSCLC Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00813332
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:00.908231+00:00
Published At
2010-01-25T00:00:00+00:00
Record Updated At
2010-01-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Advanced NSCLC", "Recurrent NSCLC"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2010-01-25"
protocolSection.identificationModule.nctId
"NCT00813332"
protocolSection.identificationModule.officialTitle
"A Double Blind , Randomized, Multicenter Study of Second Line Treatment of Endostar\uff08rh Recombined Endostatin\uff09With Single Docetaxel In NSCLC Patients"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Advanced NSCLC (protocolSection.conditionsModule.conditions)
  • Recurrent NSCLC (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.